Evidence map›Paper›PMID 42613378›Full record

ArticleNature structural & molecular biology2026

Hydrophobic interactions of FG-nucleoporins are required for dilating nuclear membrane pores into selective transport channels after mitosis.

Wanlu Zhang, Andrew P Latham, Paolo Ronchi, Sebastian Schnorrenberg, Jean-Karim Hériché, Ziqiang Huang, Catherine Sue, M Julius Hossain, Natalia Rosalia Morero, Hannah Pflaumer and 4 more

Abstract read
In one paragraph

Article in Nature structural & molecular biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors.

Wanlu ZhangCell Biology and Biophysics Unit, European Molecular Biology Laboratory, Meyerhofstrasse, Heidelberg, Germany.
Andrew P LathamDepartment of Bioengineering and Therapeutic Sciences, Department of Pharmaceutical Chemistry, Quantitative Biosciences Institute, University of California, San Francisco, San Francisco, CA, USA.ORCID http://orcid.org/0000-0002-9338-7253
Paolo RonchiElectron Microscopy Core Facility, European Molecular Biology Laboratory, Meyerhofstrasse, Heidelberg, Germany.
Sebastian SchnorrenbergImaging Centre, European Molecular Biology Laboratory, Meyerhofstrasse, Heidelberg, Germany.
Jean-Karim HérichéCell Biology and Biophysics Unit, European Molecular Biology Laboratory, Meyerhofstrasse, Heidelberg, Germany.ORCID http://orcid.org/0000-0001-6867-9425
Ziqiang HuangImaging Centre, European Molecular Biology Laboratory, Meyerhofstrasse, Heidelberg, Germany.
Catherine SueDepartment of Bioengineering and Therapeutic Sciences, Department of Pharmaceutical Chemistry, Quantitative Biosciences Institute, University of California, San Francisco, San Francisco, CA, USA.ORCID http://orcid.org/0000-0002-7463-5194
M Julius HossainCentre for Cancer Immunology, Faculty of Medicine, University of Southampton, Southampton, Southampton, UK.ORCID http://orcid.org/0000-0003-3303-5755
Natalia Rosalia MoreroCell Biology and Biophysics Unit, European Molecular Biology Laboratory, Meyerhofstrasse, Heidelberg, Germany.ORCID http://orcid.org/0000-0003-0092-5663
Hannah PflaumerCell Biology and Biophysics Unit, European Molecular Biology Laboratory, Meyerhofstrasse, Heidelberg, Germany.
Merle Hantsche-GriningerCell Biology and Biophysics Unit, European Molecular Biology Laboratory, Meyerhofstrasse, Heidelberg, Germany.ORCID http://orcid.org/0000-0002-5137-1616
Yannick SchwabCell Biology and Biophysics Unit, European Molecular Biology Laboratory, Meyerhofstrasse, Heidelberg, Germany.
Andrej SaliDepartment of Bioengineering and Therapeutic Sciences, Department of Pharmaceutical Chemistry, Quantitative Biosciences Institute, University of California, San Francisco, San Francisco, CA, USA.ORCID http://orcid.org/0000-0003-0435-6197
Jan EllenbergCell Biology and Biophysics Unit, European Molecular Biology Laboratory, Meyerhofstrasse, Heidelberg, Germany. jan.ellenberg@scilifelab.se.ORCID http://orcid.org/0000-0001-5909-701X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nuclear envelope (NE) reformation after mitosis is essential for daughter cell viability and requires tightly coordinated nuclear pore complex (NPC) assembly and nuclear membrane reformation. Here we combined acute molecular perturbations in live cells with correlative three-dimensional electron tomography or MINFLUX super-resolution microscopy to show that degrading Nup62 during mitosis arrests NPC assembly at an intermediate step with smaller membrane pores and removes the whole central transport channel. Molecular dynamics simulations predicted that 32 copies of the central channel subcomplex, recruited into the previously unoccupied pore center, can self-associate through hydrophobic interactions to occupy and expand pore volume, exerting an outward-pushing force; indeed, disrupting these interactions during NPC assembly blocked pore dilation. Later in mitotic exit, perturbed cells exhibited impaired nuclear import, smaller nuclei and looser NE spacing. Acute inhibition of nuclear import recapitulated these NE defects without affecting NPC assembly. Together, our findings reveal a two-step molecular mechanism linking NPC assembly and NE reformation. First, hydrophobic FG-nucleoporins dilate the assembling nuclear pore by forming the central transport channel, which then allows nuclear-import-driven nuclear expansion, leading to tight, regular NE membrane spacing.

Indexed as

MitosisNuclear PoreNuclear Pore Complex ProteinsActive Transport, Cell NucleusHeLa CellsHumansHydrophobic and Hydrophilic InteractionsMolecular Dynamics SimulationNuclear EnvelopeNuclear Pore Complex Proteins

Identifiers

PMID42613378
PMCPMC13561880

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.